MWNA
SCLN

Marshall Wace North America’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Marshall Wace North America’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-843,451
Closed -$9.28M – 1799
2017
Q3 		$9.28M Buy
843,451
+600,767
+248% +$6.63M 0.06% 382
2017
Q2 		$2.67M Buy
242,684
+223,144
+1,142% +$2.23M 0.02% 665
2017
Q1 		$195K Buy
+19,540
New +$195K ﹤0.01% 918